A Philadelphia jury has awarded $1.75 million to a plaintiff who alleged that taking the antipsychotic drug Risperdal caused gynecomastia, a condition in which boys grow excessive breast tissue.
The jury handed up the verdict in Murray v. Janssen Pharmaceuticals on Monday following about two weeks of trial and two-and-a-half hours of deliberations. The jury determined that Janssen Pharmaceuticals, which made the drug, failed to warn health care providers about gynecomastia as a risk of taking the drug, and the failure to warn caused plaintiff Nicholas Murray’s injuries.
